Abstract

The tumor microenvironment, including cancer-associated fibroblasts (CAF), has developed as an important target for understanding tumor progression, clinical prognosis and treatment responses of cancer. Cancer cells appear to transform normal fibroblasts (NF) into CAFs involving direct cell-cell communication and epigenetic regulations. This review summarizes the current understanding on miR involvement in cancer cell—tumor environment/stroma communication, transformation of NFs into CAFs, their involved targets and signaling pathways in these interactions; and clinical relevance of CAF-related miR expression profiles. There is evidence that miRs have very similar roles in activating hepatic (HSC) and pancreatic stellate cells (PSC) as part of precancerous fibrotic diseases. In summary, deregulated miRs affect various intracellular functional complexes, such as transcriptional factors, extracellular matrix, cytoskeleton, EMT/MET regulation, soluble factors, tyrosine kinase and G-protein signaling, apoptosis and cell cycle & differentiation, but also formation and composition of the extracellular microenvironment. These processes result in the clinical appearance of desmoplasia involving CAFs and fibrosis characterized by deregulated stellate cells. In addition, modulated release of soluble factors can act as (auto)activating feedback loop for transition of NFs into their pathological counterparts. Furthermore, epigenetic communication between CAFs and cancer cells may confer to cancer specific functional readouts and transition of NF. MiR related epigenetic regulation with many similarities should be considered as key factor in development of cancer and fibrosis specific environment.

Highlights

  • Over the years the tumor microenvironment has developed as an important target for understanding tumor progression, clinical prognosis and treatment responses of cancer, such as for chemotherapy and radiation

  • As one key event Cancer-associated fibroblasts (CAF) activation appears to induce alternative production and secretion of extracellular matrix (ECM) proteins resulting in ECM remodeling and cancer cell invasion [3]

  • By reviewing the literature we found evidence that miRs have very similar roles in the activation of hepatic (HSC) and pancreatic stellate cells (PSC) which are activated fibroblasts being part of precancerous fibrotic diseases, like pancreatic and hepatic fibrosis

Read more

Summary

Introduction

Over the years the tumor microenvironment has developed as an important target for understanding tumor progression, clinical prognosis and treatment responses of cancer, such as for chemotherapy and radiation. It is fully accepted that microRNA (miRs) are deregulated in human cancers, we are only at the beginning of elucidating whether miR expression and function in resident fibroblasts of the tumor microenvironment are affected by their interactions with cancer cells. MiRs are small noncoding RNA molecules that negatively regulate gene expression at a post-transcriptional level. Their target genes are known to affect cell differentiation, adhesion, migration, proliferation, secretion and cell-cell interaction, among others. By reviewing the literature we found evidence that miRs have very similar roles in the activation of hepatic (HSC) and pancreatic stellate cells (PSC) which are activated fibroblasts being part of precancerous fibrotic diseases, like pancreatic and hepatic fibrosis. MiR-related similarities and differences related to tumor-related cellular dysfunctions between the various types of activated fibroblasts were included in this review

Methods
Clinical Relevance of miR in CAF
Functional Consequences of miRNA Dysregulation in CAFs
TGF-β Signaling
Soluble Factors
Cell Cycle and Proliferation
MiR-Targeted Readouts for Cellular Functions
Findings
Currently known structuresinin
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call